InnovAge Holding Corp. (INNV)

In the past six months, InnovAge Holding Corp.'s stock price has been impacted by its financial performance and guidance. InnovAge's stock was trading at $5.19 on January 1, 2026, and increased by 45.9% to $7.57 by May 7, 2026. In Q1 Fiscal Year 2026, revenue exceeded analyst estimates by 4.2%, and EPS surpassed estimates by 178%. In Q2 Fiscal Year 2026, EPS and revenues exceeded analyst expectations, with EPS at $0.078 and revenue at $239.7 million. In Q3 Fiscal Year 2026, InnovAge reported total revenue of $251.9 million, but a net loss of $29.9 million due to a significant litigation charge and settlement costs of $51.9 million. InnovAge raised its earnings guidance for fiscal year 2026 multiple times and expects total revenues of $950 million to $975 million and adjusted EBITDA of $85 million to $90 million.

There appears to be some demand seasonality for InnovAge Holding Corp.'s services. Growth in member months in Q3 fiscal year 2026 was attributed to normal seasonal growth resulting from the Medicare Advantage open enrollment period, suggesting that enrollment periods can lead to seasonal increases in participant numbers.

InnovAge Holding Corp. is a healthcare delivery platform specializing in comprehensive senior care solutions through the Program of All-Inclusive Care for the Elderly (PACE) model. The company manages and provides medical and ancillary services for high-cost, frail, and dual-eligible seniors, enabling them to live independently. InnovAge's services include in-home care, in-center services, transportation, and care management, generating revenue through capitated payments from Medicare and Medicaid.

InnovAge Holding Corp. operates PACE centers across several states in the United States, including Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. As of March 31, 2026, InnovAge served approximately 8,050 participants across 20 centers in six states.

InnovAge's brand reputation has been influenced by operational improvements and financial impacts from past issues, including past regulatory issues and CMS sanctions in 2022–2023. A significant litigation charge of $51.9 million recorded in the third quarter of fiscal year 2026 heavily affected GAAP profitability, potentially impacting public perception.

InnovAge Holding Corp. has a concentrated ownership structure, with institutional investors holding the majority of its shares. Apax Partners (UK) Ltd. is the largest shareholder, holding 83.54% of the company's shares as of July 21, 2025. Welsh, Carson, Anderson & Stowe (WCAS) acquired majority ownership in May 2016 and jointly controlled the company with Apax Partners after an equity recapitalization in July 2020. T. Rowe Price Investment Management, Inc. holds 3.889% of shares as of July 21, 2025, and 4.546% as of May 4, 2026. Coliseum Capital Management LLC holds 2.895% of shares as of July 21, 2025. Vanguard Group Inc and BlackRock, Inc. are also notable institutional holders. Individual ownership accounts for a smaller portion, at 1.62%.